These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28961018)

  • 1. Reply to Hou et al.: Can Magnetic Resonance Imaging Effectively Evaluate the Prognosis of Patients with Pulmonary Arterial Hypertension?
    Swift AJ; Wild JM; Kiely DG
    Am J Respir Crit Care Med; 2018 Mar; 197(5):676-677. PubMed ID: 28961018
    [No Abstract]   [Full Text] [Related]  

  • 2. Can Magnetic Resonance Imaging Effectively Evaluate the Prognosis of Patients with Pulmonary Arterial Hypertension?
    Hou CJ; Wei R; Tang JL
    Am J Respir Crit Care Med; 2018 Mar; 197(5):675-676. PubMed ID: 28961026
    [No Abstract]   [Full Text] [Related]  

  • 3. Magnetic Resonance Imaging in Pulmonary Arterial Hypertension. Panacea or Pixelation?
    Mathai SC; Kawut SM
    Am J Respir Crit Care Med; 2017 Jul; 196(2):129-131. PubMed ID: 28707971
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic value of cardiovascular magnetic resonance imaging measurements corrected for age and sex in idiopathic pulmonary arterial hypertension.
    Swift AJ; Rajaram S; Campbell MJ; Hurdman J; Thomas S; Capener D; Elliot C; Condliffe R; Wild JM; Kiely DG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):100-6. PubMed ID: 24275955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reply to Chen
    Provencher S; Boucherat O; Berger RMF; Goumans MJ; Bonnet S
    Am J Respir Crit Care Med; 2020 May; 201(10):1313-1314. PubMed ID: 32032495
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular magnetic resonance in pulmonary hypertension.
    Bradlow WM; Gibbs JS; Mohiaddin RH
    J Cardiovasc Magn Reson; 2012 Jan; 14(1):6. PubMed ID: 22257586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Possibilities of Magnetic Resonance Tomography in Diagnosis of Pulmonary Arterial Hypertension].
    Shariya AM; Martynyuk TV; Ternovoy SK; Shariya MA
    Kardiologiia; 2021 Jul; 61(6):97-104. PubMed ID: 34311693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reply: Can treprostinil-induced early gastrointestinal side effects serve as predictors of pulmonary arterial hypertension prognosis?
    Leary PJ; Kolb TM; Maron BA; Tedford RJ; Zamanian RT
    Int J Cardiol; 2018 Aug; 264():188. PubMed ID: 29776569
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to "Diagnostic and prognostic value of echocardiography in pulmonary arterial hypertension".
    Koestenberger M; Avian A; Meinel K; Sallmon H; Hansmann G;
    Clin Cardiol; 2018 Sep; 41(9):1152-1153. PubMed ID: 30069929
    [No Abstract]   [Full Text] [Related]  

  • 10. Is magnetic resonance imaging of right ventricular volume useful clinically for evaluation of pulmonary arterial hypertension?
    Hirashiki A; Kondo T; Murohara T
    Circ J; 2012; 76(7):1595-6. PubMed ID: 22665072
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of idiopathic/hereditary pulmonary arterial hypertension.
    Matsubara H; Ogawa A
    J Cardiol; 2014 Oct; 64(4):243-9. PubMed ID: 25082294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease.
    Rajaram S; Swift AJ; Capener D; Elliot CA; Condliffe R; Davies C; Hill C; Hurdman J; Kidling R; Akil M; Wild JM; Kiely DG
    J Rheumatol; 2012 Jun; 39(6):1265-74. PubMed ID: 22589263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF165b elevation in pulmonary arterial hypertension patients, causative or adaptive? -Reply.
    Yoshihisa A; Suzuki S; Takeishi Y
    Int J Cardiol; 2018 Apr; 256():32. PubMed ID: 29454413
    [No Abstract]   [Full Text] [Related]  

  • 14. [Echocardiography and other imaging modalities in pulmonary arterial hypertension].
    Ozben B; Başaran Y
    Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():27-35. PubMed ID: 20819764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reply to "Comment on direct bilirubin as predictor of severity and mortality in idiopathic pulmonary arterial hypertension".
    Xu XQ; Zhang HD; Jing ZC
    Int J Cardiol; 2017 Jul; 239():36. PubMed ID: 28560981
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiology of pulmonary arterial hypertension.
    Taichman DB; Mandel J
    Clin Chest Med; 2013 Dec; 34(4):619-37. PubMed ID: 24267294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary hypertension owing to left heart disease.
    Mathier MA
    Clin Chest Med; 2013 Dec; 34(4):683-94. PubMed ID: 24267298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance and computed tomography imaging of the structural and functional changes of pulmonary arterial hypertension.
    Schiebler ML; Bhalla S; Runo J; Jarjour N; Roldan A; Chesler N; François CJ
    J Thorac Imaging; 2013 May; 28(3):178-93. PubMed ID: 23612440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter by Nikpour et al Regarding Article, "Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)".
    Nikpour M; Prior D; Celermajer D
    Circulation; 2016 May; 133(20):e661. PubMed ID: 27185030
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk assessment in pulmonary arterial hypertension.
    Hoeper MM; Pittrow D; Opitz C; Gibbs JSR; Rosenkranz S; Grünig E; Olsson KM; Huscher D
    Eur Respir J; 2018 Mar; 51(3):. PubMed ID: 29599117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.